• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

SignalRx Pharmaceuticals Inc

New collaboration to develop an inhalable SF2523 for lung cancer, lung fibrosis and SARS-CoV-2
August 28, 2021
Pharmaceutical News

New collaboration to develop an inhalable SF2523 for lung cancer, lung fibrosis and SARS-CoV-2

SignalRx Pharmaceuticals Inc., Crystec Ltd., and ADYA Consulting SAGL are pleased toannounce a new collaboration to develop an inhaled dry powder formulation of SF2523 for the treatmentof pulmonary fibrosis, lung cancer and SARS-CoV-2 related illnesses. SignalRx SF2523 is a novel, small molecule dual PI3K-BRD4

More
New collaboration to develop an inhalable SF2523 for lung cancer, lung fibrosis and SARS-CoV-2
Pharmaceutical News

New collaboration to develop an inhalable SF2523 for lung cancer, lung fibrosis and SARS-CoV-2

August 28, 2021

SignalRx Pharmaceuticals Inc., Crystec Ltd., and ADYA Consulting SAGL are pleased toannounce a new collaboration to develop an inhaled dry

More
  • The Benefits of a Career as a Pharmacy Technician
  • Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
  • CPHI China opens for international partnering after China rises in CPHI Index
  • Azelis inaugurates state-of-the-art Regional Innovation Center for Food & Nutrition in Singapore 
  • Why Consider a Career as a Pharmacy Technician?

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop